相关实验视频
Updated: May 31, 2026

07:54
A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
Published on: July 25, 2017
14.7K
解开肠道微生物群在细菌性肝的因果作用:一项具有临床验证的孟德尔随机化研究
Jingrun Han1,2, Han Yu2,3, Haocheng Xue2,3
1Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Pathogens (Basel, Switzerland)
|November 27, 2025
概括
肠道疾病,肠道细菌的不平衡,在细菌性肝 (BLA) 的发展中起着因果作用. 特定的细菌,如Klebsiella增加BLA风险,而Bacteroides和Bifidobacterium提供保护,建议新的治疗途径.
科学领域:
- 微生物学 微生物学
- 胃肠病学 胃肠病学
- 遗传学 是一个遗传学.
背景情况:
- 细菌性肝 (BLA) 是一种严重的肝脏感染,怀疑其发展是肠道微生物群失生症.
- 现有的因果关系证据将肠道微生物群与BLA病原体联系起来是有限的.
- 了解特定的微生物贡献对于开发有针对性的干预措施至关重要.
研究的目的:
- 系统地评估肠道微生物群在细菌性肝 (BLA) 中的因果作用,使用综合的门德尔随机化和临床队列研究.
- 为了确定与BLA风险或保护因果相关的特定微生物种群.
- 阐明肠道失调有助于BLA发育的机制.
主要方法:
- 利用来自大规模数据库 (MiBioGen,GWAS目录,泛英国生物库) 的总结级遗传数据进行孟德尔随机化分析.
- 综合遗传发现与临床队列研究进行验证.
- 在BLA患者和健康对照中分析了肠道和口腔微生物群组成,疹和肠道微生物代谢概况.
主要成果:
- 确定了Coprococcus,Veillonellaceae (包括Dialister) 和Klebsiella与BLA风险积极相关.
- 发现 Bacteroides 和 Bifidobacterium 对 BLA.有潜在的保护作用.
- 临床数据证实了BLA患者的Veillonella,Dialister和Streptococcus的丰富性,Klebsiella在疹中丰富;BLA患者的糖解路径被上调.
结论:
- 肠道失生症通过破坏微环境和代谢重编程,显著加剧细菌性肝 (BLA) 的发展.
- 特定的肠道微生物种类在BLA病因学中起因作用.
- 针对微生物群的干预措施显示出预防和治疗细菌性肝的前景.
相关概念视频
Introduction to the Human Microbiota
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota of the Large Intestine
The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...

